Among stock market sectors, tech stocks<\/a> rarely pay a strong dividend because many of them are pouring their profits back into their companies, either expanding the business or making capital expenditure investments. Healthcare companies have plenty of R&D expenses of their own, but they can be a more reliable source of dividends.<\/p>\n Stocks in the healthcare sector of the S&P 500 have an average dividend yield of 1.8%, so if you’re looking for healthcare stocks<\/a> to buy that pay a great dividend, I’m going to want stocks with a dividend yield of more than 2.5%. Here are three good choices — and they all reflect a different type of healthcare stock that you can fit into your portfolio.<\/p>\n Image source: Getty Images.<\/p>\n AbbVie<\/p>\n Illinois-based AbbVie (ABBV<\/a> +0.06%) is a major pharmaceutical company<\/a> best known for Humira, a drug that treats arthritis, Crohn’s disease, psoriasis, and other ailments, as well as its cancer medication, Imbruvica, and immunology drugs Skyrizi and Rinvoq.<\/p>\n The company has a massive market capitalization<\/a> of $385 billion, with more than $59 billion in revenue over the last 12 months. <\/p>\n Today’s Change<\/p>\n (0.06%) $0.12<\/p>\n Current Price<\/p>\n $219.16<\/p>\n Key Data Points<\/p>\n Market Cap<\/p>\n $387B<\/p>\n Day’s Range<\/p>\n $217.09 – $220.99<\/p>\n 52wk Range<\/p>\n $163.81 – $244.81<\/p>\n Volume<\/p>\n 4.6M<\/p>\n Avg Vol<\/p>\n 5.5M<\/p>\n Gross Margin<\/p>\n 69.68%<\/p>\n Dividend Yield<\/p>\n 0.03%<\/p>\n Revenue in the third quarter, just released on Oct. 31, showed $15.8 billion, up 9.1% from a year ago. The company got massive returns from Skyrizi, which generated $4.7 billion in revenue (up 46.8% from last year), and Rinvoq, which brought in $2.2 billion in revenue (up 35.3% from last year. Both of those gains helped make up for the drop in Humira revenue, which at $993 million was down 55.4% from last year. AbbVie lost exclusivity for its Humira drug in 2023, so the slower sales were expected. <\/p>\n AbbVie stock is up 20% this year, and investors also get a 3.1% dividend yield<\/a> for holding AbbVie stock. The company announced it is increasing its dividend from $1.64 per share to $1.73 per share — a 5.5% jump — payable on Feb. 17, 2026, to shareholders of record as of Jan. 16, 2026. <\/p>\n UnitedHealth Group<\/p>\n<\/p>\n
<\/p>\n